Literature DB >> 15905706

Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings.

Takayuki Yamamoto1, Maki Nakahigashi, Satoru Umegae, Tatsushi Kitagawa, Koichi Matsumoto.   

Abstract

BACKGROUND: The aim of this study was to examine the impact of elemental diet on mucosal inflammation in Crohn's disease (CD), mainly by cytokine measurements.
METHODS: Twenty-eight consecutive patients with active CD were treated with an elemental diet (Elental) for 4 weeks. The mucosal biopsies were obtained from the terminal ileum and large bowel before and after treatment. As a control group, mucosal biopsies were obtained from 20 patients without inflammation. Mucosal cytokine concentrations were measured by enzyme-linked immunosorbent assay.
RESULTS: After treatment, clinical remission was achieved in 20 patients (71%). Endoscopic healing and improvement rates were 44% and 76% in the terminal ileum and 39% and 78% in the large bowel, respectively. Histologic healing and improvement rates were 19% and 54% in the terminal ileum and 20% and 55% in the large bowel, respectively. Before treatment, the mucosal concentrations of interleukin (IL)-1beta, IL-1 receptor antagonist (IL-1ra), IL-6, IL-8, and tumor necrosis factor-alpha in the ileum and large bowel were significantly higher than in controls. These cytokine concentrations decreased to the levels of control after treatment. IL-1ra/IL-1beta ratio in the ileum and large bowel was significantly lower than in controls before treatment. The ratio increased to the level of controls after treatment. The endoscopic and histologic healing of the mucosal inflammation was associated with a decline of the mucosal cytokines and an increase of the IL-1ra/IL-1beta ratio.
CONCLUSIONS: The elemental diet (Elental) reduced mucosal cytokine production and corrected an imbalance between proinflammatory and anti-inflammatory cytokines in CD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15905706     DOI: 10.1097/01.mib.0000161307.58327.96

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  55 in total

Review 1.  An update of the role of nutritional therapy in the management of Crohn's disease.

Authors:  Moftah H Alhagamhmad; Andrew S Day; Daniel A Lemberg; Steven T Leach
Journal:  J Gastroenterol       Date:  2012-06-15       Impact factor: 7.527

2.  Elevated urinary cytokine levels in patients undergoing ileal neobladder replacement compared with sigmoid neobladder replacement.

Authors:  Yuzo Nakano; Hideaki Miyake; Taka-Aki Inoue; Atsushi Takenaka; Isao Hara; Masato Fujisawa
Journal:  Int Urol Nephrol       Date:  2007-02-20       Impact factor: 2.370

3.  Acute duodenal Crohn's disease successfully managed with low-speed elemental diet infusion via nasogastric tube: a case report.

Authors:  Takayuki Yamamoto; Maki Nakahigashi; Satoru Umegae; Tatsushi Kitagawa; Koichi Matsumoto
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

Review 4.  To feed or not to feed? Are nutritional supplements worthwhile in active Crohn's disease?

Authors:  H Lochs
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

5.  Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis.

Authors:  Takayuki Kajiura; Tomoko Takeda; Shinji Sakata; Mitsuo Sakamoto; Masaki Hashimoto; Hideki Suzuki; Manabu Suzuki; Yoshimi Benno
Journal:  Dig Dis Sci       Date:  2008-12-05       Impact factor: 3.199

6.  Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease.

Authors:  Marietta Iacucci; Subrata Ghosh
Journal:  Therap Adv Gastroenterol       Date:  2011-03       Impact factor: 4.409

Review 7.  Crohn's disease: evidence for involvement of unregulated transcytosis in disease etio-pathogenesis.

Authors:  Jay Pravda
Journal:  World J Gastroenterol       Date:  2011-03-21       Impact factor: 5.742

8.  Specialized enteral nutrition therapy in Crohn's disease patients on maintenance infliximab therapy: a meta-analysis.

Authors:  Douglas L Nguyen; Lena B Palmer; Emily T Nguyen; Stephen A McClave; Robert G Martindale; Matthew L Bechtold
Journal:  Therap Adv Gastroenterol       Date:  2015-07       Impact factor: 4.409

Review 9.  Histological healing in inflammatory bowel disease: a still unfulfilled promise.

Authors:  Vincenzo Villanacci; Elisabetta Antonelli; Karel Geboes; Giovanni Casella; Gabrio Bassotti
Journal:  World J Gastroenterol       Date:  2013-02-21       Impact factor: 5.742

Review 10.  Diet therapy for inflammatory bowel diseases: The established and the new.

Authors:  Franziska Durchschein; Wolfgang Petritsch; Heinz F Hammer
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.